<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30810679</article-id><article-id pub-id-type="pmc">6385839</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0067</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Sclerosing Mediastinitis Causing Unilateral Pulmonary Edema Due to
Left Atrial and Pulmonary Venous Compression. A Case Report and Literature
Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Panagopoulos</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Leivaditis</surname><given-names>Vasileios</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9149-1586</contrib-id><name><surname>Kraniotis</surname><given-names>Pantelis</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Ravazoula</surname><given-names>Panagiota</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Koletsis</surname><given-names>Efstratios</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Dougenis</surname><given-names>Dimitrios</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Cardiothoracic Surgery, University Hospital of
Patras, Patras, Greece. </aff><aff id="aff2">
<label>2</label> Department of Cardiothoracic and Vascular Surgery, Westpfalz
Klinikum, Kaiserslautern, Germany. </aff><aff id="aff3">
<label>3</label> Department of Radiology, University Hospital of Patras, Patras,
Greece. </aff><aff id="aff4">
<label>4</label> Department of Pathology, University Hospital of Patras, Patras,
Greece. </aff><author-notes><corresp id="c1">Correspondence Address: <bold>Pantelis Kraniotis</bold>,
https://orcid.org/0000-0001-9149-1586, University General Hospital of Patras -
Radiology, Ippokratous Av, Rion Patras 265 00 - Greece. E-mail:
<email>pantelis.kraniotis@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2019</year></pub-date><volume>34</volume><issue>1</issue><fpage>85</fpage><lpage>92</lpage><history><date date-type="received"><day>04</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>08</day><month>5</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Sclerosing mediastinitis (SM), previously named chronic fibrosing mediastinitis,
is an inflammatory process that in its end-stage results to sclerosis around the
mediastinal structures. SM is quite rare and has been correlated with
inflammatory and autoimmune diseases, as well as malignancy. SM may either
present in a mild form, with minor symptoms and a benign course or in a more
aggressive form with severe pulmonary hypertension and subsequent higher
morbidity and mortality. The diagnosis of SM may be difficult and quite
challenging, as symptoms depend on the mediastinal structure that is mainly
involved; quite often the superior vena cava. However, practically any
mediastinal structure may be involved by the fibrotic process, such as the
central airways, as well as the pulmonary arteries and veins, leading to
obstruction or total occlusion. The latter may be impossible to undergo proper
surgical excision of the lesion, and is considered to be a real challenge to the
surgeon. We herein report a case of SM that presented with arterial and venous
compression. The imaging appearance was that of unilateral pulmonary edema,
associated with lung collapse. The case is supplemented by a non-systematic
review of the relevant literature.</p></abstract><kwd-group><kwd>Mediastinitis</kwd><kwd>Pulmonary Edema</kwd><kwd>Constriction, Pathologic</kwd><kwd>Arterial Occlusive Diseases/etiology</kwd><kwd>Pulmonary Veins/Pathology</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= C-reactive protein</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Computed tomography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Erythrocyte
sedimentation rate</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MAA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Macroaggregated
albumin</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MRI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Magnetic resonance
imaging</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PET</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Positron emission
tomography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Sclerosing
mediastinitis</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Sclerosing mediastinitis (SM), formerly known as chronic fibrosing mediastinitis,
represents a slowly progressive inflammatory process causing sclerosis around the
mediastinal structures. It is a relatively rare condition that has been associated
with various causes, such as infections, inflammatory diseases, autoimmune
disorders, and malignancies<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The spectrum of the disease varies from benign with
minor symptoms, to severe with pulmonary hypertension resulting in
death<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r5" ref-type="bibr">5</xref>]</sup>. SM is a diagnostic challenge to the surgeon, since
it may involve various mediastinal structures in the fibrosing process, resulting in
compressive and/or occlusive phenomena; most commonly the superior vena cava.
Involvement of the pulmonary arteries<sup>[<xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r9" ref-type="bibr">9</xref>]</sup>, the pulmonary veins<sup>[<xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>, or the central
airways<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r16" ref-type="bibr">16</xref>-<xref rid="r20" ref-type="bibr">20</xref>]</sup> have also been described. Since complete surgical
excision of the lesion is sometimes impossible, an alternative treatment approach
may be necessary<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r21" ref-type="bibr">21</xref>-<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p><p>We report herein a rare case of SM, causing both arterial and venous compression,
resulting in unilateral pulmonary edema, which initially presented clinically as
lung atelectasis. Furthermore, a non-systematic review of the relevant literature is
also provided.</p></sec><sec sec-type="cases"><title>CASE REPORT</title><p>A 35-year-old female presented with dyspnea on exertion, fatigue and incidents of
tachycardia over the past 8 months. She also complained about intermittent,
irritating cough sometimes accompanied with blood-streaked sputum. The patient
reported being previously on oral contraceptives, for polycystic ovary disease, for
which she was finally operated. Because of increasing shortness of breath, she
underwent pulmonary workup, where the lung functional tests, including spirometry
and carbon monoxide diffusing capacity, were normal. Chest X-ray showed a right
lower lobe opacity (<xref ref-type="fig" rid="f1">Figure 1</xref>). Transthoracic
echocardiography revealed a 42 mm left atrial dilatation, accompanied with moderate
tricuspid valve regurgitation, moderate pulmonary hypertension and a measured
pulmonary artery systolic pressure of 42 mmHg. A chest computed tomography (CT) scan
(<xref ref-type="fig" rid="f2">Figure 2</xref>) revealed a solid mass, measuring
7 mm in diameter, in the lower part of the posterior mediastinum, extending 6.3 cm
downwards from the level of the carina. The mass was impinging upon the posterior
surface of the left atrium, the pulmonary vein orifices and was abutting the right
hilum. Calcifications were evident within the lesion. Areas of ground glass
opacities were noted in the right middle and lower pulmonary lobes, with thickening
of the interlobular septa especially at the periphery of the lung parenchyma,
indicative of pulmonary vein inflow obstruction. Subsequently a chest magnetic
resonance imaging (MRI; <xref ref-type="fig" rid="f3">Figure 3</xref>), confirmed
the presence of the space occupying lesion, extending to the subcarinal region. The
mass was compressing the right main pulmonary artery, the peripheral part of which
did not exceed 7 mm in diameter; it was also in close relation to the azygos vein,
the esophagus, the central part of the right mainstem bronchus and the right wall of
the descending thoracic aorta. Furthermore, it compressed the posterior aspect of
the left atrium, with obliteration of the pulmonary veins. Further workup with
fiberoptic bronchoscopy revealed hemorrhagic mucosa with evidence of external
compression and stenosis of the right lower lobe bronchus. No endobronchial mass was
found and the aspirated lavage was negative for malignancy. A lung perfusion scan
with 5 mCi of 99mTc-HAM (human albumin microspheres) followed, demonstrating minimal
uptake (5%) of the radioactive substance from the right lung, indicative of severe
hypoperfusion.</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Posterior-Anterior (PA) chest X-ray. There is an ill-defined opacity in
the right lower lung zone, with some degree of fine reticulation,
extending to the lung periphery (Kerley B lines).</p></caption><graphic xlink:href="rbccv-34-01-0085-g01"/></fig></p><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>A: Axial contrast-enhanced lung CT (mediastinal windows): There is a soft
tissue attenuation mass at the level of the right lower pulmonary veins.
The lesion abuts the posterolateral part of the right atrium. The mass
exhibits coarse calcifications in its posterior part. Note the presence
of a calcified bronchopulmonary node on the right, which could be
attributed to a previous granulomatous infection. B: High resolution CT
scan (lung windows) at the level of the lung bases, depicting thickened
interlobular septa, patchy ground glass opacities and infiltrates,
consistent with regional lung congestion due to impaired pulmonary
venous return.</p></caption><graphic xlink:href="rbccv-34-01-0085-g02"/></fig></p><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>A: Axial T1-weighted image. The mass is almost isointense to the thoracic
muscles (white asterisk). B: Coronal gradient-echo T2 image. The mass
extends upward to the subcarinal region. The lesion exhibits a
heterogeneous hypointensity (white asterisk), consistent with the
presence of fibrous component. C: Axial T1-weighted image,
post-gadolinium image. The mass (black asterisk) shows contrast uptake,
more homogeneous in its anterior part. Note that the uptake is less
homogeneous in its posterior part. Contrast uptake may represent areas
with active inflammation.</p></caption><graphic xlink:href="rbccv-34-01-0085-g03"/></fig></p><p>Differential diagnosis included teratoma, lymphoma, sarcoidosis, primary lung cancer,
metastatic carcinoma, mediastinal sarcoma or a mediastinal desmoid tumor.</p><p>Thoracotomy was decided in order to obtain definite diagnosis and also because of the
lesion location. Mediastinoscopy was technically impossible, therefore, an
exploratory right lateral thoracotomy was performed. Intraoperative findings were in
accordance to the preoperative MRI and CT scans. Surprisingly, tortuous, engorged
vessels demonstrating a rich collateral between the diaphragm and the azygos, as
well as between parietal and visceral pleura were noted. The latter indicated a slow
growing mass, which was compensated by the patient. The lesion was hard on
palpation, due to the high degree of fibrosis, with areas of calcification. It was
tightly adhering to the esophagus, the left atrium, the pulmonary vessels and the
right bronchi. Intraoperatively, multiple frozen section biopsies were obtained, as
close as possible to the center of the mass. The procedure was vigorous, due to the
hard texture of the lesion; the quick-frozen sections were returned negative for
malignancy. Mobilization of the esophagus to prevent dysphagia was performed.
Complete removal of the lesion was impossible due to its firm adherence to the
surrounding vital structures.</p><p>The patient had a relatively uncomplicated postoperative course, apart from a
transient episode of partial right lower lobe collapse, revealed in the chest X-ray
and a pneumonitis episode, which responded well to treatment with antibiotics; she
was finally discharged on the sixth postoperative day.</p><p>The pathologic examination revealed dense bands of collagen separated by a chronic
inflammatory cell infiltrate of lymphocytes and plasma cells (<xref ref-type="fig" rid="f4">Figure 4</xref>). Moreover, areas of calcification were also observed.
The process extended into the pulmonary parenchyma at the level of the hilum. Stains
for acid-fast bacilli and fungi were negative.</p><p><fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Haphazardly arranged collagen lamellae separated by an inflammatory
infiltrate.</p></caption><graphic xlink:href="rbccv-34-01-0085-g04"/></fig></p><p>After an episode of hemoptysis, she was administered steroid treatment
(methylprednisolone), based on case study reports; treatment also comprised
azathioprine, calcium, vitamin D3, isoniazide and vitamin B6 (due to positive
Mantoux test). The patient received an initial dose of 20 mg/d methylprednisolone,
which was tapered over the next few weeks to a maintenance dose of 5 mg/d. At the
beginning of the treatment, the patient demonstrated elevated inflammatory markers
[erythrocyte sedimentation rate (ESR), C-reactive protein CRP)], which were
significantly decreased a month later. She also experienced several side effects of
steroid treatment, including central obesity, facial hair increase, acne and
myopathy.</p><p>During follow-up, an MRI scan performed two years postoperatively demonstrated 15%
decrease in the dimensions of the lesion. A new MRI scan was repeated nine months
after the previous one, which showed that the dimension of the lesion remained
unchanged (<xref ref-type="fig" rid="f5">Figure 5</xref>). A new pulmonary workup
showed significant improvement in lung functional tests, compared to those two years
ago. Clinically, the patient reported moderate improvement of her dyspnea.
Additionally, postoperative echocardiography showed a measured pulmonary artery
systolic pressure of 15 mmHg. No definite etiological factor was detected, while the
patient was on follow-up. Unfortunately, the patient was lost to follow-up 4 years
postoperatively.</p><p><fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Post-treatment, follow-up, axial T1-weighted, post gadolinium image. The
mass has smaller dimensions and the contrast uptake is less intense</p></caption><graphic xlink:href="rbccv-34-01-0085-g05"/></fig></p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Fibrosing mediastinitis, also known as SM was first reported by Hunter in 1757 and
later described by Hallet in 1948<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. The disease affects mostly young adults
between 30 and 45 years old. SM is characterized by deposition of fibrous tissue
around mediastinal structures. Men are more frequently affected than
women<sup>[<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r29" ref-type="bibr">29</xref>]</sup>. SM as well as a spectrum of other disorders, such
as retroperitoneal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and
orbital pseudotumor are considered "different manifestations of a single
disease"<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>SM is a rare, benign condition. It occurs due to extensive proliferation of acellular
collagen and fibrous tissue within the mediastinum<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. It is a manifestation
of an altered immunological reaction which results in diffuse dense fibrosis, which
infiltrates mediastinal structures<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. In the majority of patients, no etiological
factor can be found and in such cases SM is considered idiopathic. Flieder et
al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>
introduced the term "idiopathic fibro-inflammatory lesion of the mediastinum" to
replace the term fibrosing mediastinitis.</p><p>Many cases of secondary SM have been linked to Histoplasma capsulatum
infections<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r33" ref-type="bibr">33</xref>]</sup>. Concerning the pathogenesis of SM, it is
postulated to be a late hypersensitivity reaction to diseases such as fungal
infections (aspergillosis, cryptococcosis, blastomycosis, mucormycosis),
tuberculosis, syphilis, as well as, immune response to radiation, drugs, trauma, and
malignancy<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r16" ref-type="bibr">16</xref>-<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r34" ref-type="bibr">34</xref>,<xref rid="r35" ref-type="bibr">35</xref>]</sup>. These aforementioned factors may stimulate
fibroblastic activity resulting in collagen deposition and fibrosis.</p><p>Moreover, the relationship between fibrosing mediastinitis and mediastinal granuloma
is also controversial; both represent varying manifestations along the temporal
spectrum of one disease process, and mediastinal granuloma is the precursor of
mediastinal fibrosis<sup>[<xref rid="r36" ref-type="bibr">36</xref>]</sup>. Interestingly, Dines et al.<sup>[<xref rid="r37" ref-type="bibr">37</xref>]</sup> reported that SM
developed over a two-year period, in 34% of patients with mediastinal granuloma. The
term mediastinal granuloma is commonly used in the setting of a focal mediastinal
mass caused by lymph node infection due to Histoplasma capsulatum species. The
lesion is typically well encapsulated, without local invasion or diffuse mediastinal
fibrosis and usually without involvement of the airways, pulmonary arteries, or
pulmonary veins<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>. Both disease entities have similar histological
characteristics, while common immunological mechanisms are involved into their
pathogenesis. However, their main difference lies in the areas they usually affect,
as well as their extent. SM originally occurs in the mediastinum and extends to the
lung parenchyma, whereas the mediastinal granuloma follows an opposite course
starting from the lung parenchyma and extending to the mediastinum. In many cases
both conditions are reported in the same patient, who may also suffer from other
fibrosing disorders, such as retroperitoneal fibrosis<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup>.</p><p>Prevalence and incidence information is unfortunately not available, due to lack of
reliable data, probably due to the disease's unclear or multifactorial
pathophysiology. Regarding the entire population who contract histoplasmosis, far
less than 1% has the excessive healing response to the fungal infection, that is the
basis of the disease. The incidence of idiopathic fibrosing mediastinitis is
estimated to be even lower.</p><p>Sherrick et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> retrospectively reviewed the radiographic findings
among 33 patients with fibrosing mediastinitis and identified two distinct patterns
of involvement: a localized pattern noted in 82% and a diffuse pattern, in 18%. The
focal pattern, manifests as a soft-tissue attenuation mass, that is frequently
calcified and is usually located in the right paratracheal, in the subcarinal
regions or in the hilum. It is most likely due to histoplasmosis and does not
improve with steroid treatment. On the other hand, the diffuse pattern manifests as
a diffusely infiltrating, non-calcified mass that involves multiple mediastinal
compartments. It is not related to histoplasmosis but often occurs in the setting of
other idiopathic fibrosing disorders such as retroperitoneal fibrosis. Treatment
with corticosteroids may result in clinical and radiographic improvement.</p><p>Patients may be asymptomatic for a long time or present with constitutional symptoms,
such as fever and weight loss. Moreover symptoms may be caused by obstruction,
compression, entrapment, strangulation or invasion of any mediastinal structure,
such as the central airways, superior vena cava, pulmonary veins, and pulmonary
arteries<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>. The sites most commonly affected are the right
paratracheal region, resulting in superior vena cava and azygos vein compression;
the subcarinal area, with obstruction of the bronchi and the pulmonary artery
laterally, while anterior extension obstructs the pulmonary vein. Obstruction of the
central airways is infrequent in patients with fibrosing mediastinitis and typically
manifests with cough, stridor, wheezing, dyspnea and hemoptysis or exhibits lung
collapse distal to the occluded airway, as in our patient. It can also be
complicated with post-obstructive pneumonia. Other structures such as the heart, the
pericardium, the coronary arteries, the aorta, and the aortic branch vessels are
much less frequently involved<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>.</p><p>Posterior mediastinal extension of the fibrosing process results in dysphagia or
broncho-esophageal fistula in cases of esophageal involvement; and, finally,
involvement of the right pulmonary hilum. Clinical symptoms may be vague and
non-specific since patients present with cough, dyspnea, hemoptysis, dysphagia and
chest pain<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. The most common presentation is superior vena cava
syndrome<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>. It can also cause pulmonary artery stenosis and
pulmonary hypertension<sup>[<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r40" ref-type="bibr">40</xref>,<xref rid="r41" ref-type="bibr">41</xref>]</sup>. Patients with pulmonary venous
occlusion<sup>[<xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup> may present with progressive or exertional dyspnea
as well as with recurrent hemoptysis. This pattern of symptoms has been called the
"pseudo-mitral stenosis syndrome". One of the most important causes of morbidity and
mortality is longstanding pulmonary venous occlusion, leading to secondary pulmonary
arterial hypertension and cor pulmonale<sup>[<xref rid="r42" ref-type="bibr">42</xref>]</sup>. Pulmonary venous occlusion may also
lead to pulmonary infarction<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup>. Pulmonary arterial stenosis or
occlusion<sup>[<xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r9" ref-type="bibr">9</xref>]</sup> caused by SM results less frequently in pulmonary
hypertension<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r42" ref-type="bibr">42</xref>]</sup>. Rare cases with involvement of the coronary
vessels<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup> or the pericardium may result in constrictive
pericarditis<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r45" ref-type="bibr">45</xref>]</sup> cause by the fibrosing process. Jain et
al.<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>
describe a case of sclerosing mediastinitis trapping the ascending aorta that was
radiographically thought to be an intramural hematoma. Miyata et
al.<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup> report a rare case of asymptomatic sclerosing
mediastinitis mimicking mediastinal tumor with pleural dissemination.</p><p>Patients present with an abnormal chest X-ray, depicting a mediastinal mass usually
in the right paratracheal area. Kerley B lines may be also present.</p><p>CT depicts more accurately the extent of the disease, along the middle mediastinal
structures and the involvement of paratracheal, subcarinal and pulmonary hilar
areas, with better demonstration of calcifications, not usually obvious on routine
X-rays<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. It also delineates the extent of vascular
involvement and obstruction as disease progresses. Pulmonary vascular occlusion may
result in pulmonary hypertension presenting as areas of diffuse lung attenuation,
and thickening of the interlobular septa<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>, as in the present case.
Intra-parenchymal bronchial dilatation and wall thickening is also known to happen
in patients with chronic pulmonary embolism. This may be the result of decreased
pulmonary arterial caliber due to chronic obstruction, compensated by airway
dilatation<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>The role of MRI in the diagnosis of fibrosing mediastinitis is questionable.
T1-weighted images show a heterogeneous, infiltrative mass of intermediate signal
intensity. Its appearance on T2-weighted images is more
variable<sup>[<xref rid="r47" ref-type="bibr">47</xref>]</sup>; regions of both increased and markedly decreased
signal intensity are frequently seen in the same lesion. MRI with flow sensitive
pulse sequences can be useful for the assessment of vascular stenoses, when
intravenous contrast material is contraindicated<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>. MR imaging can also
be useful for assessing vascular patency after percutaneous or surgical
treatment<sup>[<xref rid="r49" ref-type="bibr">49</xref>]</sup>. MRI poorly depicts calcifications and CT is
therefore considered the mainstay for diagnostic evaluation in fibrosing
mediastinitis patients<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup>.</p><p>Echocardiography may show an increase in the right ventricular end-diastolic
dimension, as well as pulmonary and tricuspid valve insufficiency and dilatation of
the main pulmonary artery, proximal to the obstruction.</p><p>Perfusion scintigraphy performed with technetium-99m-labeled macroaggregated albumin
(MAA) can show focal or diffuse perfusion defects in patients with pulmonary
arterial or venous obstruction<sup>[<xref rid="r50" ref-type="bibr">50</xref>]</sup>.</p><p>SM is usually divided into 2 types according to radiological findings. The focal type
is the most common. It is described as a localized and calcified mass in the
paratracheal or subcarinal areas of the mediastinum or in the pulmonary hilum. The
diffuse type is less common and typically not calcified. It presents as a diffusely
infiltrating mass, affecting various structures of the mediastinum. Moreover, other
findings in the lungs are also relatively common, such as infiltrates,
consolidation, and pleural effusions<sup>[<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r51" ref-type="bibr">51</xref>,<xref rid="r52" ref-type="bibr">52</xref>]</sup>.</p><p>Disease severity may be indicated using whole-body fluorine-18 fluorodeoxyglucose
(F-18 FDG) positron emission tomography (PET) scanning, since marked uptake on PET
is correlated with active disease. PET may assess inflammatory activity of the
disease, as well as the effectiveness of immunosuppressive therapy; it can also
detect other autoimmune diseases associated with fibrosing effects and can identify
disease relapse<sup>[<xref rid="r52" ref-type="bibr">52</xref>]</sup>. This imaging technique can be a useful tool for
patient management and follow-up, helping to evaluate the results of the treatment
administered<sup>[<xref rid="r53" ref-type="bibr">53</xref>]</sup>.</p><p>Accurate diagnosis of this rare condition is usually difficult since sputum cultures
are rarely indicative, skin tests are nonspecific and serological tests for fungal
diseases are rarely positive. Minimally invasive methods and exploratory surgery is
often needed in order to make a definitive diagnosis<sup>[<xref rid="r35" ref-type="bibr">35</xref>]</sup>.</p><p>Primary or idiopathic SM is histopathologically diagnosed when secondary causes of
mediastinal fibrosis have been excluded such as histoplasma, mycobacterium, and
nocardia infections, as well as Hodgkin's lymphoma, sclerosing large cell lymphoma,
sarcoidosis and autoimmune disorders<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>.</p><p>The differential diagnosis of SM includes intrathoracic desmoid, solitary fibrous
tumor, Hodgkin's lymphoma, primary mediastinal large B-cell lymphoma and
desmoplastic malignant mesothelioma<sup>[<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r47" ref-type="bibr">47</xref>]</sup>. Lesions caused by desmoid tumors are described as
more cellular and vascular. The diagnosis of solitary fibrous tumor and mesothelioma
can be excluded by positive immunostains for CD34 and keratins. Inflammatory
myofibroblastic tumor presents with increased ALK gene expression. Multifocal
fibrosclerosing lesions present with increased IgG4+ plasma
cells<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup>. Adequacy of tissue samples is very important and
diagnosing sclerosing mediastinitis in small biopsy specimens should be made with
caution<sup>[<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r54" ref-type="bibr">54</xref>,<xref rid="r55" ref-type="bibr">55</xref>]</sup>. The main histological characteristics are dense
bundles and sheets of hyalinized collagen, with relatively sparse inflammatory
infiltrate. They are microscopic hallmarks of the disease with three different
stages based on the proportion of fibrous tissue to the inflammatory
component<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>. The evolution of the disease is variable. The main
causes of death in patients suffering from SM can be summed up in infectious
diseases, excessive hemoptysis and heart failure due to cor pulmonale. Prognosis
mainly depends lesion location and structures affected. The prognosis is very good
in patients with the focal type of SM, presenting with localized mediastinal or
hilar fibrosis. On the other hand, patients, who suffer from the diffuse type,
involving subcarinal or bilateral mediastinal structures, have higher mortality
rates, up to 30%<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r38" ref-type="bibr">38</xref>]</sup>.</p><p>Treatment of SM can be conservative with use of antifungal or antimycobacterial
agents, when diagnosis is definite for infectious disease. Corticosteroids and
immunosuppressants have also been used in the treatment of SM and similar disorders,
with controversial however results<sup>[<xref rid="r22" ref-type="bibr">22</xref>-<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Most studies demonstrate that medical treatments,
including steroids have relatively poor results. However, Ikeda et
al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> reported complete resolution of the disease in a
patient with fibrosing mediastinitis and sclerosing cervicitis treated only with
prednisolone. Joury et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> describe a case of idiopathic SM, associated with
occlusion of three pulmonary veins and the left main pulmonary artery, which was
treated with initial high-dose steroids followed by maintenance steroid and
methotrexate, with very good long-term disease control. Inoue et
al.<sup>[<xref rid="r56" ref-type="bibr">56</xref>]</sup> reported a patient with SM who had elevated serum
IgG4 and increased numbers of IgG4-positive plasma cells in the mediastinal lesion,
suggesting an IgG4-related immunopathologic process involved in the pathogenesis of
the disease, similar to sclerosing pancreatitis. That patient responded well to
steroid treatment with regression of the mediastinal mass, like those suffering from
sclerosing (autoimmune) pancreatitis<sup>[<xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r56" ref-type="bibr">56</xref>]</sup>.</p><p>Tamoxifen has been administrated by Clark et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> in patients with
retroperitoneal fibrosis with promising results. Others used a combination of
tamoxifen and steroids but patients showed recurrence after cessation of
treatment<sup>[<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p><p>In cases of SM associated with histoplasmosis, antifungal treatment can be used. It
may include traditional antifungals such as amphotericin B and itraconazole or newer
agents such as voriconazole and posaconazole, which have shown promising results in
experimental models<sup>[<xref rid="r40" ref-type="bibr">40</xref>]</sup>. Antifungal therapy is typically not effective in
SM, however, some patients may benefit from it. Urschel et al.<sup>[<xref rid="r57" ref-type="bibr">57</xref>]</sup> reported that six
individuals treated with ketoconazole demonstrated recurrence of mediastinal disease
after surgical resection.</p><p>Simple conservative treatment such as diuretics may also be considered in other cases
of idiopathic forms of the disease<sup>[<xref rid="r58" ref-type="bibr">58</xref>]</sup>.</p><p>In some cases, the role of surgery may be significantly important in treating SM,
since it can improve the patient's symptoms and overall status, and may also be
curative in localized disease<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r59" ref-type="bibr">59</xref>]</sup>. Depending on the extent of the disease surgical
treatment can be performed either for complete lesion resection or only for
palliation<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup>.</p><p>Loyd et al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup> have reported that surgical procedures in 71
patients had limited benefit. Only 40% of them improved in the postoperative period,
while significantly high mortality, up to 20% was observed. Mathisen and
Grillo<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> showed that symptomatic patients who underwent
mediastinal surgery had a 22% mortality rate.</p><p>In spite of these disappointing results, surgical approach is still an important
option in certain patients. Dunn et al.<sup>[<xref rid="r59" ref-type="bibr">59</xref>]</sup> reported a case of a patient who
presented with severe right pulmonary artery stenosis. They performed successful
Dacron bypass grafting and the patient's heart failure resolved and the graft was
patent for three years. Vascular or airway surgical reconstruction is demanded when
complete surgical resection of the diseased structures is
performed<sup>[<xref rid="r60" ref-type="bibr">60</xref>]</sup>. Brown et al.<sup>[<xref rid="r51" ref-type="bibr">51</xref>]</sup> in their study reported successful
surgical strategies to relieve pulmonary artery obstruction due to SM. They reported
five patients who underwent surgical management including the creation of a double
right ventricular outflow tract and complete reconstruction of the PA confluence or
even a hybrid technique of pericardial reconstruction and
stenting<sup>[<xref rid="r51" ref-type="bibr">51</xref>]</sup>. All patients showed significant reduction of right
ventricular function.</p><p>The surgical approach is also crucial for diagnostic reasons. In most cases tissue
samples obtained by percutaneous needle technique may be limited in size and thus
insufficient to rule out malignancy; therefore, open biopsy is necessary in order to
reach a definitive diagnosis. As mentioned above, neoplasms such as solitary fibrous
tumors of the pleura, sclerosing non-Hodgkin lymphoma and the nodular sclerosis
variant of Hodgkin's disease are neoplasms included in the differential diagnosis,
and a biopsy sample is needed to exclude them<sup>[<xref rid="r59" ref-type="bibr">59</xref>,<xref rid="r60" ref-type="bibr">60</xref>]</sup>. Surgical treatment is usually contraindicated
in cases of bilateral mediastinal involvement. Overall, surgical approaches have not
been relatively promising, so far. High morbidity and mortality rates have been
noticed in patients who underwent extensive surgical resections. Surgery is also
rarely indicated in patients with SM associated with histoplasmosis, since fatal
complications may occur due to intense mediastinal fibrosis<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. If surgery is deemed
necessary, it should be performed as early as possible in the disease course and
only by experienced surgeons, in order to increase the possibilities of a favorable
outcome<sup>[<xref rid="r29" ref-type="bibr">29</xref>,<xref rid="r41" ref-type="bibr">41</xref>]</sup>.</p><p>Percutaneous intravascular stenting techniques have recently become an alternative
treatment option, with divergent but promising results. Stenting of major hilar
structures has been used for palliation<sup>[<xref rid="r38" ref-type="bibr">38</xref>]</sup>. It is an effective treatment for
central vascular obstruction, caused by SM, providing significant relief of anatomic
obstruction and sustained clinical improvement<sup>[<xref rid="r61" ref-type="bibr">61</xref>]</sup>. It has also been used for the
treatment of superior vena cava obstruction in cases of SM caused by
histoplasmosis<sup>[<xref rid="r51" ref-type="bibr">51</xref>,<xref rid="r52" ref-type="bibr">52</xref>]</sup>. Smith et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> presented a case of an adult with
pulmonary artery stenosis due to fibrosing mediastinitis induced by histoplasmosis
which was successfully treated with cutting balloon angioplasty and stent placement.
Doyle et al.<sup>[<xref rid="r62" ref-type="bibr">62</xref>]</sup> showed that such stents could be applied in
stenotic lesions in both pulmonary arteries and veins. However, they were unable to
establish flow in all stented vessels because of in-stent restenosis. Intense
fibrotic reaction, causing chronic vascular obstruction, and resulting in
irreversible vascular remodeling is considered responsible for
restenosis<sup>[<xref rid="r62" ref-type="bibr">62</xref>]</sup>. Restenosis limits the long-term effectiveness of
percutaneous intravascular stenting techniques. It has been well described in
patients with pulmonary artery stenosis due to histoplasmosis. It is believed that
less pulmonary artery in-stent restenosis may occur after cutting balloon
procedures<sup>[<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r63" ref-type="bibr">63</xref>]</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In our patient, complete mass removal was technically not feasible, due to intense
fibrosis of the lesion and its firm adherence to the neighboring vital structures.
Partial removal was only possible and mobilization of the esophagus was performed in
order to prevent dysphagia. According to the literature, since surgical removal is
associated with high mortality rates and even though after removal of the lesion the
amelioration of symptoms may not be possible, conservative treatment was decided for
our patient based on the data of the preoperative exams in conjunction with the
histopathological results. Postoperatively, our patient received antituberculous
therapy, combined with corticosteroids and showed moderate symptomatic improvement,
mainly concerning her dyspnea, and marked decrease of her pulmonary hypertension.
Long-term follow-up reached four years postoperatively. No episodes of recurrent
hemoptysis were observed until then. She was later lost to follow-up.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">NP</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VL</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PK</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PR</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EK</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DD</td><td align="left" valign="top" rowspan="1" colspan="1">Conception or design of the work;
acquisition, analysis, or interpretation of data for the work; final
approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at University Hospital of Patras, Patras, Greece.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>D</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name><name><surname>Argania</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>AS</given-names></name><name><surname>Halushka</surname><given-names>MK</given-names></name></person-group><article-title>Unexpected sclerosing mediastinitis involving the ascending aorta
in the setting of a multifocal fibrosclerotic disorder</article-title><source>Pathol Res Pract</source><year>2011</year><volume>207</volume><issue>1</issue><fpage>60</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">20594766</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis Jr</surname><given-names>FW</given-names></name><name><surname>Andrus</surname><given-names>EC</given-names></name></person-group><article-title>Mitral stenosis in facsimile</article-title><source>N EngI J Med</source><year>1954</year><volume>251</volume><issue>8</issue><fpage>297</fpage><lpage>302</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinkle</surname><given-names>JK</given-names></name></person-group><article-title>Fibrous mediastinitis presenting as mitral
stenosis</article-title><source>J Thorac Cardiovasc Surg</source><year>1971</year><volume>62</volume><issue>1</issue><fpage>161</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">5091680</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittredge</surname><given-names>RD</given-names></name><name><surname>Nash</surname><given-names>AD</given-names></name></person-group><article-title>The many facets of sclerosing fibrosis</article-title><source>Am J Roentgenol Radium Ther Nucl Med</source><year>1974</year><volume>122</volume><issue>2</issue><fpage>288</fpage><lpage>298</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>JE</given-names></name><name><surname>Burchell</surname><given-names>HB</given-names></name></person-group><article-title>Multilobar pulmonary venous obstruction with pulmonary
hypertension; protective arterial lesions in the involved
lobes</article-title><source>AMA Arch Intern Med</source><year>1951</year><volume>87</volume><issue>3</issue><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">14810262</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosio</surname><given-names>FG</given-names></name><name><surname>Gobel</surname><given-names>FL</given-names></name><name><surname>Harrincton</surname><given-names>DP</given-names></name><name><surname>Sako</surname><given-names>Y</given-names></name></person-group><article-title>Pulmonary arterial stenosis with wide splitting of the second
heart sound due to mediastinal fibrosis</article-title><source>Am J Cardiol</source><year>1973</year><volume>31</volume><issue>3</issue><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">4569273</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>DE</given-names></name><name><surname>Buccigrossi</surname><given-names>D</given-names></name><name><surname>Peabody</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>KL</given-names></name><name><surname>Moser</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Pulmonary vascular occlusion and fibrosing
mediastinitis</article-title><source>Chest</source><year>1986</year><volume>89</volume><issue>2</issue><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">3943394</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>WP</given-names></name><name><surname>Lundberg</surname><given-names>GD</given-names></name><name><surname>Dickerson</surname><given-names>RB</given-names></name></person-group><article-title>Pulmonary artery obstruction and cor pulmonale due to chronic
fibrous mediastinitis</article-title><source>Am J Med</source><year>1965</year><volume>38</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">14256724</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>DS</given-names></name><name><surname>Cheema</surname><given-names>JI</given-names></name><name><surname>Costello</surname><given-names>P</given-names></name></person-group><article-title>Fibrosing mediastinitis with peripheral airway dilatation and
central pulmonary artery occlusion</article-title><source>J Thorac Imaging</source><year>2004</year><volume>19</volume><issue>3</issue><fpage>204</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">15273619</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botticelli</surname><given-names>JT</given-names></name><name><surname>Schlueter</surname><given-names>DP</given-names></name><name><surname>Lange</surname><given-names>RL</given-names></name></person-group><article-title>Pulmonary venous and arterial hypertension due to chronic fibrous
mediastinitis. Hemodynamics and pulmonary function</article-title><source>Circulation</source><year>1966</year><volume>33</volume><issue>6</issue><fpage>862</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">5940515</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dye</surname><given-names>TE</given-names></name><name><surname>Saab</surname><given-names>SB</given-names></name><name><surname>Almond</surname><given-names>CH</given-names></name><name><surname>Watson</surname><given-names>L</given-names></name></person-group><article-title>Sclerosing mediastinitis with occlusion of pulmonary
veins</article-title><source>J Thorac Cardiovasc Surg</source><year>1977</year><volume>74</volume><issue>1</issue><fpage>136</fpage><lpage>141</lpage></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindelglass</surname><given-names>IL</given-names></name><name><surname>Trubowitz</surname><given-names>S</given-names></name></person-group><article-title>Pulmonary vein obstruction: an uncommon sequel to chronic fibrous
mediastinitis</article-title><source>Ann Intern Med</source><year>1958</year><volume>48</volume><issue>4</issue><fpage>876</fpage><lpage>891</lpage><pub-id pub-id-type="pmid">13521614</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yacoub</surname><given-names>MH</given-names></name><name><surname>Thomson</surname><given-names>VC</given-names></name></person-group><article-title>Chronic idiopathic pulmonary hilar fibrosis: a clinicopathology
entity</article-title><source>Thorax</source><year>1971</year><volume>26</volume><fpage>365</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">5565782</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasser</surname><given-names>WK</given-names></name><name><surname>Feigenbaum</surname><given-names>H</given-names></name><name><surname>Fisch</surname><given-names>C</given-names></name></person-group><article-title>Clinical and hemodynamic diagnosis of pulmonary venous
obstruction due to sclerosing mediastinitis</article-title><source>Am J Cardiol</source><year>1967</year><volume>20</volume><issue>5</issue><fpage>725</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">6053520</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>WA</given-names></name><name><surname>Tronic</surname><given-names>BS</given-names></name><name><surname>Levitan</surname><given-names>N</given-names></name><name><surname>Webb-Johnson</surname><given-names>DC</given-names></name><name><surname>Shahian</surname><given-names>DM</given-names></name><name><surname>Ellis Jr</surname><given-names>FH</given-names></name></person-group><article-title>Pulmonary venous infarction</article-title><source>Chest</source><year>1992</year><volume>102</volume><issue>3</issue><fpage>937</fpage><lpage>940</lpage><pub-id pub-id-type="pmid">1516426</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherrick</surname><given-names>AD</given-names></name><name><surname>Brown</surname><given-names>LR</given-names></name><name><surname>Harms</surname><given-names>GF</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name></person-group><article-title>The radiographic findings of fibrosing
mediastinitis</article-title><source>Chest</source><year>1994</year><volume>106</volume><issue>2</issue><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">7774324</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kounz</surname><given-names>PD</given-names></name><name><surname>Molina</surname><given-names>PL</given-names></name><name><surname>Sagel</surname><given-names>SS</given-names></name></person-group><article-title>Fibrosing mediastinitis in the posterior thorax</article-title><source>AJR Am J Roentgenol</source><year>1989</year><volume>153</volume><issue>3</issue><fpage>489</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">2763944</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>E</given-names></name><name><surname>Soler</surname><given-names>R</given-names></name><name><surname>Pombo</surname><given-names>F</given-names></name><name><surname>Requejo</surname><given-names>I</given-names></name><name><surname>Montero</surname><given-names>C</given-names></name></person-group><article-title>Fibrosing mediastinitis: CT and MR findings</article-title><source>Clin Radiol</source><year>1998</year><volume>53</volume><issue>12</issue><fpage>907</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">9867275</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>JB</given-names></name><name><surname>Abronberg</surname><given-names>DJ</given-names></name><name><surname>Sagel</surname><given-names>SS</given-names></name></person-group><article-title>CT of fibrosing mediastinitis: findings and their
utility</article-title><source>AJR Am J Roentgenol</source><year>1983</year><volume>141</volume><issue>2</issue><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">6603112</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>SE</given-names></name><name><surname>McAdams</surname><given-names>HP</given-names></name><name><surname>Rosaso-de-Christenson</surname><given-names>ML</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name></person-group><article-title>Galvin Fibrosing mediastinitis</article-title><source>Radiograhics</source><year>2001</year><volume>21</volume><issue>3</issue><fpage>737</fpage><lpage>757</lpage></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joury</surname><given-names>AU</given-names></name><name><surname>Al Boukai</surname><given-names>AA</given-names></name><name><surname>Kashour</surname><given-names>TS</given-names></name></person-group><article-title>Severe fibrosing mediastinitis with atypical presentation:
effective control with novel therapeutic approach</article-title><source>Ann Thorac Med</source><year>2017</year><volume>12</volume><issue>3</issue><fpage>209</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">28808494</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Nomori</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Iwatani</surname><given-names>K</given-names></name><name><surname>Yoshimoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Successful steroid treatment for fibrosing mediastinitis and
sclerosing cervicitis</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>83</volume><issue>3</issue><fpage>1199</fpage><lpage>1201</lpage><pub-id pub-id-type="pmid">17307498</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinzbrunner</surname><given-names>B</given-names></name><name><surname>Ritter</surname><given-names>S</given-names></name><name><surname>Domingo</surname><given-names>J</given-names></name><name><surname>Rosenthal</surname><given-names>CJ</given-names></name></person-group><article-title>Remission of rapidly growing desmoid tumors after tamoxifen
therapy</article-title><source>Cancer</source><year>1983</year><volume>52</volume><issue>12</issue><fpage>2201</fpage><lpage>2204</lpage><pub-id pub-id-type="pmid">6640490</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname><given-names>SD</given-names></name><name><surname>Madison</surname><given-names>J</given-names></name><name><surname>Fechner</surname><given-names>RE</given-names></name><name><surname>Levine</surname><given-names>PA</given-names></name></person-group><article-title>Cervical manifestations of fibrosing mediastinitis: a diagnostic
and therapeutic dilemma</article-title><source>Head Neck</source><year>1993</year><volume>15</volume><issue>6</issue><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">8253566</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>DE</given-names></name><name><surname>Skubi</surname><given-names>KB</given-names></name><name><surname>Van Eyes</surname><given-names>J</given-names></name><name><surname>Motulsky</surname><given-names>AG</given-names></name></person-group><article-title>Familial multifocal fibrosclerosis. Findings suggesting that
retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis,
Riedel's thyroiditis, and pseudotumor of the orbit may be different
manifestations of a single disease</article-title><source>Ann Intern Med</source><year>1967</year><volume>66</volume><issue>5</issue><fpage>884</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">6025229</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>CP</given-names></name><name><surname>Vanderpool</surname><given-names>D</given-names></name><name><surname>Preskitt</surname><given-names>JT</given-names></name></person-group><article-title>The response of retroperitoneal fibrosis to
tamoxifen</article-title><source>Surgery</source><year>1991</year><volume>109</volume><issue>4</issue><fpage>502</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">2008655</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savelli</surname><given-names>BA</given-names></name><name><surname>Parshley</surname><given-names>M</given-names></name><name><surname>Morganroth</surname><given-names>ML</given-names></name></person-group><article-title>Successful treatment of sclerosing cervicitis and fibrosing
mediastinitis with tamoxifen</article-title><source>Chest</source><year>1997</year><volume>111</volume><issue>4</issue><fpage>1137</fpage><lpage>1140</lpage><pub-id pub-id-type="pmid">9106605</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eggleston</surname><given-names>JC</given-names></name></person-group><chapter-title>Sclerosing mediastinitis</chapter-title><person-group person-group-type="editor"><name><surname>Fenoglio</surname><given-names>CM</given-names></name><name><surname>Wolff</surname><given-names>M</given-names></name></person-group><source>Progress in surgical pathology</source><volume>2</volume><publisher-loc>New York</publisher-loc><publisher-name>Masson</publisher-name><year>1980</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathisen</surname><given-names>DJ</given-names></name><name><surname>Grillo</surname><given-names>HC</given-names></name></person-group><article-title>Clinical manifestation of mediastinal fibrosis and
histoplasmosis</article-title><source>Ann Thorac Surg</source><year>1992</year><volume>54</volume><issue>6</issue><fpage>1053</fpage><lpage>1057</lpage><pub-id pub-id-type="pmid">1449286</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JS</given-names></name><name><surname>Kadiev</surname><given-names>S</given-names></name><name><surname>Diaz</surname><given-names>P</given-names></name><name><surname>Cheatham</surname><given-names>J</given-names></name></person-group><article-title>Pulmonary artery stenosis secondary to fibrosing mediastinitis:
management with cutting balloon angioplasty and endovascular
stenting</article-title><source>Vasc Endovascular Surg</source><year>2011</year><volume>45</volume><issue>2</issue><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">21278182</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharadwaj</surname><given-names>R</given-names></name><name><surname>Madakshira</surname><given-names>MG</given-names></name><name><surname>Bharadwaj</surname><given-names>P</given-names></name><name><surname>Sidhu</surname><given-names>HS</given-names></name></person-group><article-title>Sclerosing mediastinitis presenting as complete heart
block</article-title><source>J Clin Diagn Res</source><year>2017</year><volume>11</volume><issue>5</issue><fpage>ED12</fpage><lpage>ED14</lpage></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flieder</surname><given-names>DB</given-names></name><name><surname>Suster</surname><given-names>S</given-names></name><name><surname>Moran</surname><given-names>CA</given-names></name></person-group><article-title>Idiopathic fibroinflammatory (fibrosing/sclerosing) lesions of
the mediastinum: a study of 30 cases with emphasis on morphologic
heterogeneity</article-title><source>Mod Pathol</source><year>1999</year><volume>12</volume><issue>3</issue><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">10102610</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Tillman</surname><given-names>BF</given-names></name><name><surname>Atkinson</surname><given-names>JB</given-names></name><name><surname>Des Prez</surname><given-names>RM</given-names></name></person-group><article-title>Mediastinal fibrosis complicating histoplasmosis</article-title><source>Medicine (Baltimore)</source><year>1988</year><volume>67</volume><issue>5</issue><fpage>295</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">3045478</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parish</surname><given-names>JM</given-names></name><name><surname>Marschke Jr</surname><given-names>RF</given-names></name><name><surname>Dines</surname><given-names>DE</given-names></name><name><surname>Lee</surname><given-names>RE</given-names></name></person-group><article-title>Etiologic considerations in superior vena cava
syndrome</article-title><source>Mayo Clin Proc</source><year>1981</year><volume>56</volume><issue>7</issue><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">7253702</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parish</surname><given-names>JM</given-names></name><name><surname>Rosenow 3rd</surname><given-names>EC</given-names></name></person-group><article-title>Mediastinal granuloma and mediastinal fibrosis</article-title><source>Semin Respir Crit Care Med</source><year>2002</year><volume>23</volume><issue>2</issue><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">16088606</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schowengerdt</surname><given-names>CG</given-names></name><name><surname>Suyemoto</surname><given-names>R</given-names></name><name><surname>Main</surname><given-names>FB</given-names></name></person-group><article-title>Granulomatous and fibrous mediastinitis. A review and analysis of
180 cases</article-title><source>J Thorac Cardiovasc Surg</source><year>1969</year><volume>57</volume><issue>3</issue><fpage>365</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">5773205</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dines</surname><given-names>DE</given-names></name><name><surname>Payne</surname><given-names>WS</given-names></name><name><surname>Bernatz</surname><given-names>PE</given-names></name><name><surname>Pairolero</surname><given-names>PC</given-names></name></person-group><article-title>Mediastinal granuloma and fibrosing mediastinitis</article-title><source>Chest</source><year>1979</year><volume>75</volume><issue>3</issue><fpage>320</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">421573</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>E</given-names></name><name><surname>Aubry</surname><given-names>MC</given-names></name></person-group><article-title>Pulmonary pseudoneoplasms</article-title><source>Arch Pathol Lab Med</source><year>2010</year><volume>134</volume><issue>3</issue><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">20196669</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Krasopoulos</surname><given-names>G</given-names></name><name><surname>Ibrahim</surname><given-names>M</given-names></name><name><surname>Venn</surname><given-names>G</given-names></name></person-group><article-title>Sclerosing mediastinitis with aortic valve regurgitation and
aortic root dilatation</article-title><source>J R Soc Med</source><year>2000</year><volume>93</volume><issue>2</issue><fpage>83</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">10740579</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>LJ</given-names></name><name><surname>Conces</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>SD</given-names></name><name><surname>Blue-Hnidy</surname><given-names>D</given-names></name><name><surname>Loyd</surname><given-names>J</given-names></name></person-group><article-title>Pulmonary histoplasmosis syndromes: recognition, diagnosis, and
management</article-title><source>Semin Respir Crit Care Med</source><year>2004</year><volume>25</volume><issue>2</issue><fpage>129</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">16088457</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname><given-names>R</given-names></name><name><surname>Aguila</surname><given-names>V</given-names></name><name><surname>Mohiuddin</surname><given-names>SM</given-names></name><name><surname>Khan</surname><given-names>IA</given-names></name></person-group><article-title>Fibrosing mediastinitis presenting as pulmonary stenosis:
stenting works</article-title><source>Int J Cardiol</source><year>2007</year><volume>118</volume><issue>3</issue><fpage>e85</fpage><lpage>e86</lpage><pub-id pub-id-type="pmid">17399816</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>EN</given-names></name><name><surname>Bacos</surname><given-names>JM</given-names></name><name><surname>Macher</surname><given-names>AM</given-names></name><name><surname>Marsh</surname><given-names>HB</given-names></name><name><surname>Savage</surname><given-names>DD</given-names></name><name><surname>Fulmer</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Fibrosing mediastinitis causing pulmonary arterial hypertension
without pulmonary venous hypertension. Clinical and necropsy
observations</article-title><source>Am J Med</source><year>1977</year><volume>63</volume><issue>4</issue><fpage>634</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">910811</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzenstein</surname><given-names>AL</given-names></name><name><surname>Mazur</surname><given-names>MT</given-names></name></person-group><article-title>Pulmonary infarct: an unusual manifestation of fibrosing
mediastinitis</article-title><source>Chest</source><year>1980</year><volume>77</volume><issue>4</issue><fpage>521</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">7357976</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochrane</surname><given-names>A</given-names></name><name><surname>Warren</surname><given-names>R</given-names></name><name><surname>Mullerworth</surname><given-names>M</given-names></name><name><surname>Manolas</surname><given-names>E</given-names></name></person-group><article-title>Fibrosing mediastinitis with coronary artery
involvement</article-title><source>Ann Thorac Surg</source><year>1991</year><volume>51</volume><issue>4</issue><fpage>652</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">2012426</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>PC</given-names></name><name><surname>Shub</surname><given-names>C</given-names></name><name><surname>Lie</surname><given-names>JT</given-names></name></person-group><article-title>Constrictive pericarditis associated with combined idiopathic
retroperitoneal and mediastinal fibrosis</article-title><source>Mayo Clin Proc</source><year>1984</year><volume>59</volume><issue>5</issue><fpage>300</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">6727421</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Takahama</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>R</given-names></name><name><surname>Nakajima</surname><given-names>R</given-names></name><name><surname>Tada</surname><given-names>H</given-names></name></person-group><article-title>Sclerosing mediastinitis mimicking anterior mediastinal
tumor</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>88</volume><issue>1</issue><fpage>293</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">19559253</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rholl</surname><given-names>KS</given-names></name><name><surname>Levitt</surname><given-names>RG</given-names></name><name><surname>Glazer</surname><given-names>HS</given-names></name></person-group><article-title>Magnetic resonance imaging of fibrosing
mediastinitis</article-title><source>AJR Am J Roentgenol</source><year>1985</year><volume>145</volume><issue>2</issue><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">3875221</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farmer</surname><given-names>DW</given-names></name><name><surname>Moore</surname><given-names>E</given-names></name><name><surname>Amparo</surname><given-names>E</given-names></name><name><surname>Webb</surname><given-names>WR</given-names></name><name><surname>Gamsu</surname><given-names>G</given-names></name><name><surname>Higgins</surname><given-names>CB</given-names></name></person-group><article-title>Calcific fibrosing mediastinitis: demonstration of pulmonary
vascular obstruction by magnetic resonance imaging</article-title><source>AJR Am J Roentgenol</source><year>1984</year><volume>143</volume><issue>6</issue><fpage>1189</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">6333789</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitt</surname><given-names>RG</given-names></name><name><surname>Glazer</surname><given-names>HS</given-names></name><name><surname>Gutierrez</surname><given-names>F</given-names></name><name><surname>Moran</surname><given-names>J</given-names></name></person-group><article-title>Magnetic resonance imaging of spiral vein graft bypass of
superior vena cava in fibrosing mediastinitis</article-title><source>Chest</source><year>1986</year><volume>90</volume><issue>5</issue><fpage>676</fpage><lpage>680</lpage><pub-id pub-id-type="pmid">3769568</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>AJ</given-names></name><name><surname>Weismann</surname><given-names>I</given-names></name><name><surname>Billingsley</surname><given-names>JL</given-names></name><name><surname>Lundy</surname><given-names>MN</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Graham</surname><given-names>GD</given-names></name><etal/></person-group><article-title>Angiographic and scintigraphic findings in fibrosing
mediastinitis</article-title><source>Clin Nucl Med</source><year>1983</year><volume>8</volume><issue>4</issue><fpage>167</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">6221853</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>ML</given-names></name><name><surname>Cede&#x000f1;o</surname><given-names>AR</given-names></name><name><surname>Edell</surname><given-names>ES</given-names></name><name><surname>Hagler</surname><given-names>DJ</given-names></name><name><surname>Schaff</surname><given-names>HV</given-names></name></person-group><article-title>Operative strategies for pulmonary artery occlusion secondary to
mediastinal fibrosis</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>88</volume><issue>1</issue><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">19559232</pub-id></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Washino</surname><given-names>S</given-names></name><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Matsuzaki</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>(18)F-Fluorodeoxyglucose positron emission tomography for
diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated
with mediastinal fibrosis</article-title><source>Ann Nucl Med</source><year>2010</year><volume>24</volume><issue>3</issue><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">20112003</pub-id></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imran</surname><given-names>MB</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name><name><surname>Yoshioka</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sclerosing mediastinitis: findings on fluorine-18
fluorodeoxyglucose positron emission tomography</article-title><source>Clin Nucl Med</source><year>1999</year><volume>24</volume><issue>5</issue><fpage>305</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">10232465</pub-id></element-citation></ref><ref id="r54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotty</surname><given-names>TB</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><name><surname>Gay</surname><given-names>PC</given-names></name><name><surname>Pisani</surname><given-names>RJ</given-names></name></person-group><article-title>Desmoplastic malignant mesothelioma masquerading as sclerosing
mediastinitis: a diagnostic dilemma</article-title><source>Hum Pathol</source><year>1992</year><volume>23</volume><issue>1</issue><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">1544676</pub-id></element-citation></ref><ref id="r55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flannery</surname><given-names>MT</given-names></name><name><surname>Espino</surname><given-names>M</given-names></name><name><surname>Altus</surname><given-names>P</given-names></name><name><surname>Messina</surname><given-names>J</given-names></name><name><surname>Wallach</surname><given-names>PM</given-names></name></person-group><article-title>Hodgkin's disease masquerading as sclerosing
mediastinitis</article-title><source>South Med J</source><year>1994</year><volume>87</volume><issue>9</issue><fpage>921</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">8091258</pub-id></element-citation></ref><ref id="r56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Nose</surname><given-names>N</given-names></name><name><surname>Nishikawa</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Zen</surname><given-names>Y</given-names></name><name><surname>Kawaguchi</surname><given-names>M</given-names></name></person-group><article-title>Successful treatment of sclerosing mediastinitis with a high
serum IgG4 level</article-title><source>Gen Thorac Cardiovasc Surg</source><year>2007</year><volume>55</volume><issue>10</issue><fpage>431</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">18018609</pub-id></element-citation></ref><ref id="r57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urschel Jr</surname><given-names>HC</given-names></name><name><surname>Razzuk</surname><given-names>MA</given-names></name><name><surname>Netto</surname><given-names>GJ</given-names></name><name><surname>Disiere</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>SY</given-names></name></person-group><article-title>Sclerosing mediastinitis: improved management with histoplasmosis
titer and ketoconazole</article-title><source>Ann Thorac Surg</source><year>1990</year><volume>50</volume><issue>2</issue><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">2383106</pub-id></element-citation></ref><ref id="r58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name></person-group><article-title>Fibrosing mediastinitis with pulmonary hypertension as a
complication of pulmonary vein stenosis: A case report and review of the
literature</article-title><source>Medicine (Baltimore)</source><year>2018</year><volume>97</volume><issue>4</issue><elocation-id>e9694</elocation-id><pub-id pub-id-type="pmid">29369193</pub-id></element-citation></ref><ref id="r59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>EJ</given-names></name><name><surname>Ulicny Jr</surname><given-names>KS</given-names></name><name><surname>Wright</surname><given-names>CB</given-names></name><name><surname>Gottesman</surname><given-names>L</given-names></name></person-group><article-title>Surgical implications of sclerosing mediastinitis. A report of
six cases and review of the literature</article-title><source>Chest</source><year>1990</year><volume>97</volume><issue>2</issue><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">2404701</pub-id></element-citation></ref><ref id="r60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mole</surname><given-names>TM</given-names></name><name><surname>Glover</surname><given-names>J</given-names></name><name><surname>Sheppard</surname><given-names>MN</given-names></name></person-group><article-title>Sclerosing mediastinitis: a report on 18 cases</article-title><source>Thorax</source><year>1995</year><volume>50</volume><issue>3</issue><fpage>280</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">7660343</pub-id></element-citation></ref><ref id="r61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albers</surname><given-names>EL</given-names></name><name><surname>Pugh</surname><given-names>ME</given-names></name><name><surname>Hill</surname><given-names>KD</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Doyle</surname><given-names>TP</given-names></name></person-group><article-title>Percutaneous vascular stent implantation as treatment for central
vascular obstruction due to fibrosing mediastinitis</article-title><source>Circulation</source><year>2011</year><volume>123</volume><issue>13</issue><fpage>1391</fpage><lpage>1399</lpage><pub-id pub-id-type="pmid">21422386</pub-id></element-citation></ref><ref id="r62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>TP</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Robbins</surname><given-names>IM</given-names></name></person-group><article-title>Percutaneous pulmonary artery and vein stenting: a novel
treatment for mediastinal fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>164</volume><issue>4</issue><fpage>657</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">11520733</pub-id></element-citation></ref><ref id="r63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="editor"><name><surname>Kandzari</surname><given-names>DE</given-names></name><name><surname>Warner</surname><given-names>JJ</given-names></name><name><surname>O'Laughlin</surname><given-names>MP</given-names></name><name><surname>Harrison</surname><given-names>JK</given-names></name></person-group><article-title>Percutaneous stenting of right pulmonary artery stenosis in
fibrosing mediastinitis</article-title><source>Catheter Cardiovasc Interv</source><year>2000</year><volume>49</volume><issue>3</issue><fpage>321</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">10700067</pub-id></element-citation></ref></ref-list></back></article>